The High-Stakes Paradox of GLP-1 Medications: Value, Budgets, and the Battle for Insurance Coverage
Executive Overview In the modern landscape of modern pharmacology, few interventions have sparked as much public enthusiasm, clinical promise, and fiscal panic as glucagon-like peptide-1 (GLP-1) receptor agonists. Blockbuster medications…